Bader M, Li Y, Lecca D, Rubovitch V, Tweedie D, Glotfelty E, et al
Published findings include: Clean endocrine profile (no significant ACTH/cortisol/prolactin spike) GH peak at approximately 40 minutes post-injection Return to baseline within 3 hours No significant hunger stimulation (unlike GHRP-6)
Based on the current MHRA-approved SmPC for injectable tirzepatide (Mounjaro), the following guidance would likely apply to any future oral formulation, though specific contraindications may differ if such a product is eventually authorised
Aim for a minimum of 0.8 grams of protein per pound of target body weight daily
Thymosin 4 activates ILK and promotes cardiac cell migration, survival and repair
doi: 10.1038/nchembio.209 45 PocaiACarringtonPEAdamsJRWrightMEiermannGZhuLet al